&lt;Glenwood Inc> said it isrecalling lot number 54238 of its potaba tablet (aminobenzoatepotassium), a prescription drug used mainly to treatscleroderma, a painful skin thickening condition.    It said 5,474 bottles of 100 tablets were distributednationwide. The product is made by Vitarine Pharmaceuticals ofSpringfield Gardens, N.Y, exclusively under the Glenwood label.    Glenwood said the recall is due to the pacakging of anon-prescription tablet containing ammonium chloride andcaffeine with the potaba tablets.    Only one lot number is involved, but the company said iturges all potaba tablets purchased since January 1987 be discontinued if a lot number cannot be identified.    It said potaba therapy requires about 24 tablets a day, andin the mispackaged bottles patients could take excessivelylarge doses of caffeine and chloride which could produce rapidheart beats, anxiety, and other ill health effects. Reuter&#3;